Antiretroviral therapy from 1996-2000
Eiros, J.M.; Ortega, M.; Moreno, M.; Mantecón, M.; Castrodeza, J.; Ortiz de Lejarazu, R.
Revista espanola de quimioterapia publicacion oficial de la Sociedad Espanola de Quimioterapia 16(1): 65-73
2003
ISSN/ISBN: 0214-3429 PMID: 12750760 Document Number: 559619
A retrospective study was carried out from September 1996 to June 2000 and examined the antiretroviral therapies prescribed to HIV patients in whom the viral load had been determined. Triple therapy was the most frequently prescribed during the study and the annual percentage increased to 60% in the last semesters analyzed. Large variability in antiretroviral combinations was observed and depended on the clinical center and unit. The number of individuals who began viral-load monitoring before being treated with antiretroviral drugs showed a progressive increase.
Document emailed within 1 workday
Related Documents
Alvi, Y.; Khalique, N.; Ahmad, A.; Khan, H.S.; Faizi, N. 2019: World Health Organization Dimensions of Adherence to Antiretroviral Therapy: a Study at Antiretroviral Therapy Centre, Aligarh Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 44(2): 118-124Meintjes, G.; Black, J.; Conradie, F.; Dlamini, S.; Maartens, G.; Manzini, T.C.; Mathe, M.; Moorhouse, M.; Moosa, Y.; Nash, J.; Orrell, C.; Venter, F.; Wilson, D. 2015: Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy Southern African journal of HIV medicine 16(1): 428
Sharma, S.; Khadga, P.; Dhungana, G.P.; Chitrakar, U. 2013: Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal Kathmandu University Medical Journal 11(41): 50-53
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Mahy, M.; Lewden, C.; Brinkhof, M.W.G.; Dabis, F.; Tassie, J.-M.; Souteyrand, Y.; Stover, J. 2010: Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy Sexually Transmitted Infections 86(Suppl 2): Ii28-Ii34
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Thuret, I. 2004: Infection à VIH de l'enfant : quand débuter le traitement antirétroviral ? - When to initiate antiretroviral therapy in HIV-infected children? Archives de Pediatrie (Paris) 11(12): 1521-1524
Boulle, A.; Orrel, C.; Kaplan, R.; Van Cutsem, G.; McNally, M.; Hilderbrand, K.; Myer, L.; Egger, M.; Coetzee, D.; Maartens, G.; Wood, R. 2007: Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort Antiviral therapy 12(5): 753-760
Diouf, A.; Youbong, T.J.; Maynart, M.; Ndoye, M.; Diéye, F.L.; Ndiaye, N.A.; Koita-Fall, M.B.; Ndiaye, B.; Seydi, M. 2017: Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription Revue d'Epidemiologie et de Sante Publique 65(4): 295-300
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Humphreys, E.H.; Chang, L.W.; Harris, J. 2010: Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database of Systematic Reviews 6: Cd006517
Rajesh, L.; Karunaianantham, R.; Narayanan, P.R.; Swaminathan, S. 2009: Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients Aids Research and Human Retroviruses 25(11): 1179-1185
Hamers, R.L.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Conradie, F.; Botes, M.E.; Wellington, M.; Osibogun, A.; Sigaloff, K.C.E.; Nankya, I.; Schuurman, R.; Wit, F.W.; Stevens, W.S.; van Vugt, Mèle.; de Wit, T.F.Rinke.; Mandaliya, K.; Abdallah, S.; Jao, I.; Dolan, M.; Schuurman, R.; Wensing, A.M.; Hamers, R.L.; Sigaloff, K.C.E.; Straatsma, E.; Wit, F.W.; van Vugt, M.; Lange, J.M.; Rinke de Wit, T.F.; Osibogun, A.; Akanmu, S.; Botes, M.E.; Conradie, F.; Ive, P.; Sanne, I.; Wallis, C.L.; Letsoalo, E.; Stevens, W.S.; Hardman, M.; Kityo, C.; Namayanja, G.; Nakatudde, L.; Nankya, I.; Kiconco, M.; Abwola, M.; Mugyenyi, P.; Ndembi, N.; Lyagoba, F.; Kaleebu 2011: HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Lancet. Infectious Diseases 11(10): 750-759
Lailulo, Y.; Kitenge, M.; Jaffer, S.; Aluko, O.; Nyasulu, P.S. 2020: Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis Systematic Reviews 9(1): 292
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Newman, H.; Breunig, L.; van Zyl, G.; Stich, A.; Preiser, W. 2014: A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 387-391
Huerga, H.; Shiferie, F.; Grebe, E.; Giuliani, R.; Farhat, J.Ben.; Van-Cutsem, G.; Cohen, K. 2017: A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa Bmc Infectious Diseases 17(1): 653
Muhamadi, L.; Tumwesigye, N.M.; Kadobera, D.; Marrone, G.; Wabwire-Mangen, F.; Pariyo, G.; Peterson, S.; Ekström, A.M. 2011: Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda Pan African Medical Journal 8: 40
Vergne, L.; Malonga-Mouellet, G.; Mistoul, I.; Mavoungou, R.; Mansaray, H.; Peeters, M.; Delaporte, E. 2002: Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries Journal of Acquired Immune Deficiency Syndromes 29(2): 165-168